BioLineRx Ltd. (TLV:BLRX)

BioLineRx Revenue

BioLineRx had revenue of $477.00K USD in the quarter ending March 31, 2026, with 87.06% growth. This brings the company's revenue in the last twelve months to $1.40M, down -93.72% year-over-year. In the year 2025, BioLineRx had annual revenue of $1.18M, down -95.92%.

• Revenue (ttm): $1.40M
• Revenue Growth: -93.72%
• P/S Ratio: 9.47
• Revenue / Employee: $58.42K
• Employees: 24
• Market Cap: 41.94M ILS

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.18M	-27.76M	-95.92%
Dec 31, 2024	28.94M	24.14M	502.92%
Dec 31, 2023	4.80M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 2, 2026

Data Sources Report a data error